AWA
BIIB icon

Arkadios Wealth Advisors’s Biogen BIIB Stock Holding History

Arkadios Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$877K Buy
4,781
+206
+5% +$38K 0.01% 849
2025
Q4 		$805K Buy
4,575
+1,679
+58% +$274K 0.02% 797
2025
Q3 		$406K Sell
2,896
-107
-4% -$14.5K 0.01% 1034
2025
Q2 		$377K Sell
3,003
-351
-10% -$43.7K 0.01% 964
2025
Q1 		$459K Buy
+3,354
New +$479K 0.02% 737
2022
Q1 		– Sell
-897
Closed -$215K – 561
2021
Q4 		$215K Sell
897
-494
-36% -$127K 0.03% 533
2021
Q3 		$393K Sell
1,391
-152
-10% -$49.8K 0.06% 344
2021
Q2 		$534K Buy
1,543
+334
+28% +$101K 0.07% 314
2021
Q1 		$338K Buy
1,209
+98
+9% +$26.4K 0.06% 326
2020
Q4 		$272K Buy
1,111
+995
+858% +$257K 0.06% 274
2020
Q3 		$32.5K Sell
116
-2
-2% -$558 0.02% 494
2020
Q2 		$33.2K Buy
118
+24
+26% +$7.21K 0.02% 440
2020
Q1 		$29.7K Sell
94
-29
-24% -$8.8K 0.02% 420
2019
Q4 		$41.1K Buy
+123
New +$34.1K 0.02% 340

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Arkadios Wealth Advisors's BIIB Position: Q1 2026 in Review

Arkadios Wealth Advisors increased its Biogen (BIIB) stake by 4.5% in Q1 2026, buying an estimated $38K and bringing the position to 4,781 shares worth $877K. The position accounts for 0.01% of the portfolio, ranked #849.

Arkadios Wealth Advisors first reported a position in BIIB in Q4 2019 and has held it in 14 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Arkadios Wealth Advisors held 4,781 shares of Biogen worth $877K as of Q1 2026.
  • Arkadios Wealth Advisors bought 206 Biogen shares in Q1 2026, an estimated $38K.
  • Biogen made up 0.01% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #849 holding.
  • Arkadios Wealth Advisors first reported a position in Biogen in Q4 2019 and has held it in 14 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.